Coming Soon: Conexiant’s news site is becoming MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more.
Rheumatology
Partner With Us
Advertisement
Conexiant chevron_right Rheumatology chevron_right FDA Approves Prefilled Syringe for Cortrophin Gel
FDA & Government News

FDA Approves Prefilled Syringe for Cortrophin Gel

FDA approves a prefilled syringe format for Purified Cortrophin Gel, reducing administration steps for patients with inflammatory and autoimmune conditions.

MDSpire News
article Full Article subject Summary summarize Notecard
ANI Pharmaceuticals has received FDA approval for a prefilled syringe format for Purified Cortrophin Gel, designed to simplify administration for patients. The drug is indicated for various conditions including acute exacerbations of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, among others. However, caution is advised for patients with comorbid conditions and during pregnancy due to potential risks.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Company

Follow Us

Copyright © 2026 MDSpire News unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.